1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 3: 
The detection of specific metabolites (Lac, Ala, and Lip) at TE = 144 ms for the HISE and PRESS SVS scans, respectivelya
No.SexAge (yr)Pathologic DiagnosisHISEPRESS
LacAlaLipLacAlaLip
Case 1F71Acoustic neuroma+−+−−+
Case 2M47Acoustic neuroma+−−−−−
Case 3M52Metastases (lung origin)+?+−−+
Case 4M58Metastases (gastrointestinal origin)+−+−−+
Case 5M61Non-Hodgkin lymphoma+−+−−+
Case 6M66Meningioma, WHO I++−−−−
Case 7F52Meningioma, WHO I++−−−−
Case 8F67Meningioma, WHO I+?−+−−
Case 9F43Meningioma, WHO II++−−+−
Case 10M52Meningioma, WHO I+?+−−+
Case 11F34Meningioma, WHO I++−−?−
Case 12F56Meningioma, WHO I−−+−−+
Case 13F50Meningioma, WHO I++−−−−
Case 14F58Meningioma, WHO I−++−?+
Case 15F42Oligodendroglioma, WHO III+−−−−−
Case 16F49Oligodendroglioma, WHO II+−−−−−
Case 17F35GBM, WHO IV+−−−−+
Case 18M45GBM, WHO IV+?+−−+
Case 19F64GBM, WHO IV+?++−+
Case 20F67GBM, WHO IV+−−−−+
Case 21F70GBM, WHO IV+?+−−+
Case 22M66GBM, WHO IV+−−+−+
Case 23F69GBM, WHO IV+−++−+
  • Note:—F indicates female; M, male; WHO, World Health Organization; GBM, glioblastoma.
  • ↵a The plus sign represents the detection of strong signal peaks; the question mark represents the presence of faint or inconspicuous signal peaks; and the minus sign represents the almost undetectable signal peaks.